Ajay Niranjan, MD, specializes in neurosurgery. He practices at the University of Pittsburgh Physicians, Department of Neurological Surgery and is affiliated with UPMC Presbyterian.  Dr. Niranjan is associate professor of neurological surgery at the University of Pittsburgh School of Medicine. He received his medical degree from King George’s Medical College in Lucknow, India, where he also completed his neurosurgical residency. Dr. Niranjan then completed a fellowship in image-guided neurosurgery at the University of Pittsburgh. A leading expert on stereotactic radiosurgery, Dr. Niranjan has helped develop guidelines for stereotactic radiosurgery for trigeminal neuralgia, pituitary adenomas, arteriovenous malformations, acoustic neuromas, and brain metastases. Dr. Niranjan has co-authored more than 120 articles in journals such as Neurosurgery, Journal of Neurosurgery, and Journal of Neuro-oncology; contributed more than 55 book chapters; and edited two books on stereotactic radiosurgery. Dr. Niranjan is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Schwannoma, Brain Tumor, Metastatic Brain Tumor, Gamma Knife Radiosurgery, and Rhizotomy.

John C. Flickinger, MD, FACR, is a professor of radiation oncology and neurological surgery at the University of Pittsburgh School of Medicine. Dr. Flickinger holds an interest in spine tumors, brain tumors, metastatic diseases, effects of radiation on normal tissue, and the mathematical modeling of radiation response. Dr. Flickinger is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Metastatic Brain Tumor, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Vertebroplasty, and Gamma Knife Radiosurgery.

Dr. Zinn is assistant professor of neurological surgery at the University of Pittsburgh School of Medicine and associate director of the Adult Neurosurgical Oncology Program. He specializes in neurosurgical oncology. Dr. Zinn received his medical degree from the University of Zurich in Switzerland and received his PhD from the University of Lausanne. He completed his neurosurgery residency at Baylor College of Medicine and MD Anderson Cancer Center. He then completed a fellowship at Dana-Farber Cancer Institute, Harvard Medical School. In addition to his clinical focus in neuro-oncology, Dr. Zinn’s research focuses on patient-centered care for brain and spinal tumors. Utilizing humanoid brain organoid cancer models, Dr. Zinn simulates the patient’s tumor condition in the laboratory and studies the origins of how the tumor forms and how tumors can be treated using tumor genetics precision approaches. Furthermore, Dr. Zinn is developing personalized biologically-adaptable and patient-tailored, virus-based therapies for brain cancer. Pascal Zinn, MD, PhD, specializes in surgical oncology and neurosurgery. He practices at University of Pittsburgh Physicians, Department of Neurological Surgery and is affiliated with UPMC Magee-Womens Hospital, UPMC Presbyterian, and UPMC Shadyside. He completed his residency at Baylor College of Medicine and medical degree at University of Zurich. Dr. Zinn is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, Awake Craniotomy, and Cordotomy.

Steven Burton, MD, is an associate professor of radiation oncology at the University of Pittsburgh School of Medicine. Dr. Burton holds an interest in stereotactic radiosurgery, lymphoma, lung cancer, pancreas cancer, and spinal metastasis. Dr. Burton is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, Pancreaticoduodenectomy, and Gamma Knife Radiosurgery.

Jan Drappatz, MD, is a neuro-oncologist, an associate professor at the University of Pittsburgh School of Medicine, and the director of the Neuro-oncology program at UPMC. Dr. Drappatz specializes in the treatment of primary and metastatic brain tumors and neurologic complications of cancer. Dr. Drappatz is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.

Shirley Ong, MD, specializes in hematology oncology and is board-certified in neurology by the American Board of Psychiatry and Neurology. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ong received her medical degree from the University of the East Ramon Magsaysay Memorial Medical Center and completed her residency at Saint Louis University School of Medicine, followed by a fellowship at the University of Texas MD Anderson Cancer Center. Dr. Ong is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Lawrence Lunsford is a Neurosurgery provider in Pittsburgh, Pennsylvania. Dr. Lunsford is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Meningioma, Acoustic Neuroma, Schwannoma, Gamma Knife Radiosurgery, and Rhizotomy.

Leonard Appleman is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Appleman is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, and Chromophobe Renal Cell Carcinoma.

Frank Lieberman is a Neurologist in Pittsburgh, Pennsylvania. Dr. Lieberman is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri.

Vikram C. Gorantla, MD, specializes in the treatment of sarcoma, breast cancer, gastrointestinal malignancies, and head and neck cancers. Board-certified in internal medicine and medical oncology, he received his medical degree at the University of Texas Southwestern Medical School in Dallas. He completed his internal medicine residency at Washington University, St. Louis, MO, and his hematology/oncology fellowship at UPMC. Dr. Gorantla has a dedicated day seeing breast cancer patients at the Magee-Womens Cancer Progam. He also collaborates with surgical oncologists and gynecologists/oncologists to provide multidisciplinary care to patients. Dr. Gorantla is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Breast Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Gamma Knife Radiosurgery, and Endoscopy.

John Austin Vargo IV, MD, is a radiation oncologist specializing in breast cancer and gynecologic malignancies, including image-based brachytherapy and stereotactic radiotherapy. Dr. Vargo is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Vaginal Cancer, Cervical Cancer, Endometrial Cancer, Endoscopy, and Pancreaticoduodenectomy.

Costas G. Hadjipanayis, MD, PhD, is a board-certified neurosurgeon who has devoted his entire career to the treatment of brain tumor patients. He completed his neurosurgical residency and graduate PhD training at the University of Pittsburgh with additional neurosurgical oncology training at the University of California, San Francisco. Dr. Hadjipanayis is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Glioma, Glioblastoma, Astrocytoma, Gamma Knife Radiosurgery, and Awake Craniotomy.

Serah Choi, MD, PhD, specializes in radiation oncology and is board certified in radiation oncology by the American Board of Radiology. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Mercy. Dr. Choi completed her medical education at University of Pittsburgh School of Medicine and residency at University of California San Francisco. Dr. Choi is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, Glioma, and Gamma Knife Radiosurgery.

Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC).

Roby A. Thomas, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Thomas is trained in the management of all cancers and blood disorders with a focus in genitourinary and gastrointestinal malignancies. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Prostate Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Gamma Knife Radiosurgery, and Endoscopy.

Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Adult Soft Tissue Sarcoma, Merkel Cell Carcinoma, Liposarcoma, Chondrosarcoma, and Gamma Knife Radiosurgery.

Daniel P. Petro, MD, is a medical oncologist and hematologist at Hillman Cancer Center. He treats all cancer types, and has a special interest in a multidisciplinary approach to thoracic malignancies. Dr. Petro is also heavily involved in the research of Phase I trials. Dr. Petro is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Awake Craniotomy.

Megan M. Mantica, MD, is an assistant professor of neurology and medicine at the University of Pittsburgh School of Medicine in the division of hematology/oncology. She specializes in the treatment of adult high grade gliomas, central nervous system lymphoma, and neurological complications of cancer treatment. Her translational research interests include womenís neuro-oncology, reproductive neuro-oncology and metastatic brain disease, and high grade gliomas. Dr. Mantica is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Glioma, Brain Tumor, Glioblastoma, and Astrocytoma.

Jaime Mullin, DO, is a medical oncologist at UPMC Hillman Cancer Center. Dr. Mullin is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Small Cell Lung Cancer (SCLC), Posterior Fossa Tumor, Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Gastrostomy.

Melissa K. Yee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center.  She specializes in the treatment of solid tumors and blood disorders. Dr. Yee is board-certified by the American Board of Internal Medicine in medical oncology, hematology, and internal medicine.  She received her medical degree from the Drexel University College of Medicine in Philadelphia. She then completed her internal medicine residency and hematology/oncology fellowship at UPMC. She earned her undergraduate degree from Tufts University. After completion of her medical training, she was on staff at Dana Farber Cancer Institute in Boston before returning to Pittsburgh to practice at UPMC Mercy. Dr. Yee is a member of the American Society of Clinical Oncology, American Association for Cancer Research, and American Society of Hematology, and Massachusetts Medical Society. Dr. Yee is rated as an Experienced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Pleuropulmonary Blastoma.